GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Selling and Marketing Expense

Beta Drugs (NSE:BETA) Selling and Marketing Expense : ₹0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Beta Drugs's Selling and Marketing Expense for the six months ended in Sep. 2024 was ₹0 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil.

Beta Drugs Selling and Marketing Expense Historical Data

The historical data trend for Beta Drugs's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs Selling and Marketing Expense Chart

Beta Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.55 17.43 27.14 32.85 41.42

Beta Drugs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Beta Drugs Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Drugs Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Beta Drugs's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Beta Drugs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Selling and Marketing Expense
Comparable Companies
BOM:539872 BOM:590006 BOM:524164 BOM:524669 BOM:543389 BOM:500672 BOM:507789 BOM:524470 BOM:543329 BOM:532612 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Website
https://www.betadrugslimited.com
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries of which key revenue is derived from the sales made in India.

Beta Drugs Headlines

No Headlines